Omeros reported $627K in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Acelrx Pharmaceuticals ACRX:US USD 7K 140K
Adma Biologics ADMA:US USD 20K 0
Aerie Pharmaceuticals AERI:US USD 49K 1000
Alnylam Pharmaceuticals ALNY:US USD 1.23M 20K
Biomarin Pharmaceutical BMRN:US USD 186K 0
Cytokinetics CYTK:US USD 93K 8K
Heron Therapeutics HRTX:US USD 1.19M 163K
Insmed INSM:US USD 1.22M 18K
Intercept Pharmaceuticals ICPT:US USD 41K 11K
Knight Therapeutics Inc GUD:CN CAD 607.76M 4.2M
Macrogenics MGNX:US USD 615K 0
Mirati Therapeutics MRTX:US USD 58K 2K
Omeros OMER:US USD 627K 0
Pacira Pharmaceuticals PCRX:US USD 46K 0
Regulus Therapeutics RGLS:US USD 17K 2K
Sangamo Biosciences SGMO:US USD 1.62M 85K
Sarepta Therapeutics SRPT:US USD 9K 0
United Therapeutics UTHR:US USD 700K 0
Vertex Pharmaceuticals VRTX:US USD 2.6M 0
Vital Therapies VTL:US USD 3K 0
Xoma XOMA:US USD 86K 0